Symbol | Company | Weighting |
---|---|---|
CYTK | CYTOKINETICS INC | 4.43% |
IMVT | IMMUNOVANT INC | 4.16% |
NTRA | NATERA INC | 4.06% |
LLY | ELI LILLY CORP | 3.93% |
MOH | MOLINA HEALTHCARE INC | 3.26% |
PCVX | VAXCYTE INC | 3.25% |
COR | CENCORA INC | 3.22% |
CERE | CEREVEL THERAPEUTICS HLD | 3.11% |
IQV | IQVIA HOLDINGS INC | 2.96% |
AVTR | AVANTOR, INC. | 2.96% |
EXEL | EXELIXIS INC | 2.87% |
HCA | HCA HOLDINGS INC | 2.84% |
OPCH | OPTION CARE HEALTH, INC. | 2.79% |
AMGN | AMGEN CORP | 2.78% |
RGEN | REPLIGEN CORP | 2.77% |
DXCM | DEXCOM INC | 2.64% |
ALGN | ALIGN TECHNOLOGY INC | 2.56% |
WST | WEST PHARMACEUTICAL SERVICES INC | 2.54% |
EW | EDWARDS LIFESCIENCES CORP | 2.44% |
XENE | XENON PHARMACEUTICALS | 2.42% |
ABT | ABBOTT LABORATORIES | 2.39% |
ARGX | ARGENX SE ADR | 2.29% |
BAX | BAXTER INTERNATIONAL INC | 2.28% |
ZBH | ZIMMER BIOMET HOLDINGS INC | 2.27% |
JNJ | JOHNSON & JOHNSON | 2.26% |
BMRN | BIOMARIN PHARAMCEUTICAL INC | 2.21% |
RVTY | REVVITY INC | 2.14% |
ZTS | ZOETIS INC | 2.10% |
MDGL | MADRIGAL PHARMACEUTICALS | 2.02% |
SRPT | SAREPTA THERAPEUTICS INC | 1.95% |
MASI | MASIMO CORP | 1.90% |
RCM | R1 RCM INC | 1.81% |
ALNY | ALNYLAM PHARMACEUTICALS INC. | 1.81% |
INSP | INSPIRE MEDICAL SYSTEMS, INC. | 1.67% |
DNLI | DENALI THERAPEUTICS INC. | 1.63% |
APLS | APELLIS PHARMACEUTICALS INC | 1.54% |
BIIB | BIOGEN INC | 1.54% |
ILMN | ILLUMINA INC | 1.53% |
ETNB | 89BIO INC | 1.47% |
AKRO | AKERO THERAPEUTICS INC | 1.21% |
KDNYES | CONTRA CHINOOK THERAPE + NPV | 0.00% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Partners Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Fund Management (Europe) Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Partners India Management. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.